1. Home
  2. CODX vs RETO Comparison

CODX vs RETO Comparison

Compare CODX & RETO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CODX
  • RETO
  • Stock Information
  • Founded
  • CODX 2013
  • RETO 1999
  • Country
  • CODX United States
  • RETO China
  • Employees
  • CODX N/A
  • RETO N/A
  • Industry
  • CODX Medical/Dental Instruments
  • RETO Multi-Sector Companies
  • Sector
  • CODX Health Care
  • RETO Consumer Discretionary
  • Exchange
  • CODX Nasdaq
  • RETO Nasdaq
  • Market Cap
  • CODX 23.6M
  • RETO 19.9M
  • IPO Year
  • CODX 2017
  • RETO 2017
  • Fundamental
  • Price
  • CODX $0.73
  • RETO $0.93
  • Analyst Decision
  • CODX Hold
  • RETO
  • Analyst Count
  • CODX 1
  • RETO 0
  • Target Price
  • CODX $1.50
  • RETO N/A
  • AVG Volume (30 Days)
  • CODX 187.1K
  • RETO 42.5K
  • Earning Date
  • CODX 11-07-2024
  • RETO 12-30-2024
  • Dividend Yield
  • CODX N/A
  • RETO N/A
  • EPS Growth
  • CODX N/A
  • RETO N/A
  • EPS
  • CODX N/A
  • RETO N/A
  • Revenue
  • CODX $7,321,012.00
  • RETO $3,841,142.00
  • Revenue This Year
  • CODX N/A
  • RETO N/A
  • Revenue Next Year
  • CODX N/A
  • RETO N/A
  • P/E Ratio
  • CODX N/A
  • RETO N/A
  • Revenue Growth
  • CODX 57.16
  • RETO N/A
  • 52 Week Low
  • CODX $0.70
  • RETO $0.86
  • 52 Week High
  • CODX $2.23
  • RETO $5.00
  • Technical
  • Relative Strength Index (RSI)
  • CODX 24.04
  • RETO 41.08
  • Support Level
  • CODX $0.70
  • RETO $0.91
  • Resistance Level
  • CODX $0.87
  • RETO $1.10
  • Average True Range (ATR)
  • CODX 0.06
  • RETO 0.07
  • MACD
  • CODX -0.00
  • RETO 0.00
  • Stochastic Oscillator
  • CODX 12.00
  • RETO 26.17

About CODX Co-Diagnostics Inc.

Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

About RETO ReTo Eco-Solutions Inc.

ReTo Eco-Solutions Inc is a manufacturer and distributor of eco-friendly construction materials and fly-ash, as well as equipment used to produce these eco-friendly construction materials. The company engaged in providing consultation, design, project implementation and construction of urban ecological environments for capturing, controlling and re-using rainwater. It operates through four segments namely Machinery and Equipment sales, Construction materials sales, Municipal Construction Projects, and Technology Consulting and other services. The company earns its revenue from Machinery and Equipment sales segment. Geographically, it derives a majority of its revenue from China.

Share on Social Networks: